| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Radiation Biology Center, Kyoto University, Yoshida-Konoecho, Sakyo-ku, Kyoto 606 [N. N., I. S., M. I., K. I.]; and Second Department of Internal Medicine [N. N., Y. F., T. K., R. K., T. S., M. F., M. A., K. N.] and First Department of Surgery [I. S.], Kyoto University Faculty of Medicine, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606, Japan
We analyzed the genetic alterations of the cyclin D1 and INT-2 genes in hepatocellular carcinomas (HCCs) from 45 patients. Among these, expression of the cyclin D1 mRNA was also analyzed in 18 of them by Northern blotting. The cyclin D1 gene was amplified 316 fold in five HCCs (11%); among these, the INT-2 gene was also amplified 210 fold in four HCCs. We analyzed the mRNA of cyclin D1 in four HCCs with gene amplifications, and 610 fold overexpressions were detected in all of them. Because the cyclin D1 gene was amplified in patients at an advanced stage of HCC with rapid tumor growth, it appeared to be associated with the aggressive behavior of tumors. Studies on loss of heterozygosity on chromosome 13q, where the retinoblastoma (RB) gene is located, indicated that all HCCs with an amplified cyclin D1 gene retained heterozygosity on chromosome 13q. These results suggest that amplification and overexpression of the cyclin D1 gene result in the rapid growth of a subset of HCC, even though the function of the RB gene is retained.
1 This work was supported in part by a Grant-in-Aid from the Ministry of Education, Science and Culture, Japan.
2 To whom requests for reprints should be addressed.
Received 3/ 7/94. Accepted 5/ 4/94.
This article has been cited by other articles:
![]() |
N.-S. Oh, J.-S. Park, Y.-J. Jeon, J.-H. Oh, S.-Y. Jeong, J.-O. Yang, Y.-W. Park, H.-S. Yoo, and N.-S. Kim Generation of Expression Clone Set for Functional Proteomics of Human Gastric and Liver Cancers Experimental Biology and Medicine, October 1, 2009; 234(10): 1220 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Song, K. Krishnan, K. Liu, and R. S. Bresalier Polyphenon E Inhibits the Growth of Human Barrett's and Aerodigestive Adenocarcinoma Cells by Suppressing Cyclin D1 Expression Clin. Cancer Res., January 15, 2009; 15(2): 622 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Chiang, A. Villanueva, Y. Hoshida, J. Peix, P. Newell, B. Minguez, A. C. LeBlanc, D. J. Donovan, S. N. Thung, M. Sole, et al. Focal Gains of VEGFA and Molecular Classification of Hepatocellular Carcinoma Cancer Res., August 15, 2008; 68(16): 6779 - 6788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katzenellenbogen, L. Mizrahi, O. Pappo, N. Klopstock, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, E. Domany, E. Galun, et al. Molecular Mechanisms of Liver Carcinogenesis in the Mdr2-Knockout Mice Mol. Cancer Res., November 1, 2007; 5(11): 1159 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yasui, H. Yamamoto, C. Y. Ngan, B. Damdinsuren, Y. Sugita, H. Fukunaga, J. Gu, M. Maeda, I. Takemasa, M. Ikeda, et al. Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor-Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization Clin. Cancer Res., August 1, 2006; 12(15): 4720 - 4729. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huynh, K. C. Soo, P. K.H. Chow, L. Panasci, and E. Tran Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs. Clin. Cancer Res., July 15, 2006; 12(14): 4306 - 4314. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Katzenellenbogen, O. Pappo, H. Barash, N. Klopstock, L. Mizrahi, D. Olam, J. Jacob-Hirsch, N. Amariglio, G. Rechavi, L. A. Mitchell, et al. Multiple adaptive mechanisms to chronic liver disease revealed at early stages of liver carcinogenesis in the mdr2-knockout mice. Cancer Res., April 15, 2006; 66(8): 4001 - 4010. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sterpetti, L. Marucci, C. Candelaresi, D. Toksoz, G. Alpini, L. Ugili, G. S. Baroni, G. Macarri, and A. Benedetti Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G624 - G632. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Patil, I. Gutgemann, J. Zhang, C. Ho, S.-T. Cheung, D. Ginzinger, R. Li, K. J. Dykema, S. So, S.-T. Fan, et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma Carcinogenesis, December 1, 2005; 26(12): 2050 - 2057. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Lewis, D. S. Klimstra, N. D. Socci, S. Xu, J. A. Koutcher, and H. E. Varmus The Absence of p53 Promotes Metastasis in a Novel Somatic Mouse Model for Hepatocellular Carcinoma Mol. Cell. Biol., February 15, 2005; 25(4): 1228 - 1237. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. ZENDER, W. XUE, C. CORDON-CARDO, G.J. HANNON, R. LUCITO, S. POWERS, P. FLEMMING, M.S. SPECTOR, and S.W. LOWE Generation and Analysis of Genetically Defined Liver Carcinomas Derived from Bipotential Liver Progenitors Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 251 - 261. [Abstract] [PDF] |
||||
![]() |
A Ramburan, F Oladiran, C Smith, G P Hadley, and D Govender Microsatellite analysis of the adenomatous polyposis coli (APC) gene and immunoexpression of {beta} catenin in nephroblastoma: a study including 83 cases treated with preoperative chemotherapy J. Clin. Pathol., January 1, 2005; 58(1): 44 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Okochi, K. Hibi, M. Sakai, S. Inoue, S. Takeda, T. Kaneko, and A. Nakao Methylation-Mediated Silencing of SOCS-1 Gene in Hepatocellular Carcinoma Derived from Cirrhosis Clin. Cancer Res., November 1, 2003; 9(14): 5295 - 5298. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Iida, C. H. Anna, J. Hartis, M. Bruno, B. Wetmore, J. R. Dubin, S. Sieber, L. Bennett, M. L. Cunningham, R. S. Paules, et al. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643 Carcinogenesis, April 1, 2003; 24(4): 757 - 770. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Kim and X. W. Wang Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases? Carcinogenesis, March 1, 2003; 24(3): 363 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-Z. Yuan, X. Zhou, D. B. Zimonjic, M. E. Durkin, and N. C. Popescu Amplification and Overexpression of the EMS 1 Oncogene, a Possible Prognostic Marker, in Human Hepatocellular Carcinoma J. Mol. Diagn., February 1, 2003; 5(1): 48 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Birrer, D. Birrer, and J. V. Klavins Hepatocellular Carcinoma and Hepatitis Virus Ann. Clin. Lab. Sci., January 1, 2003; 33(1): 39 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fukuda, M. Ebara, M. Okuyama, N. Sugiura, M. Yoshikawa, H. Saisho, R. Shimizu, N. Motoji, A. Shigematsu, and T. Watayo Increased metabolizing activities of the tricarboxylic acid cycle and decreased drug metabolism in hepatocellular carcinoma Carcinogenesis, December 1, 2002; 23(12): 2019 - 2023. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Okochi, K. Hibi, T. Uemura, S. Inoue, S. Takeda, T. Kaneko, and A. Nakao Detection of Mitochondrial DNA Alterations in the Serum of Hepatocellular Carcinoma Patients Clin. Cancer Res., September 1, 2002; 8(9): 2875 - 2878. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzui, M. Masuda, J. T. E. Lim, C. Albanese, R. G. Pestell, and I. B. Weinstein Growth Inhibition of Human Hepatoma Cells by Acyclic Retinoid Is Associated with Induction of p21CIP1 and Inhibition of Expression of Cyclin D1 Cancer Res., July 15, 2002; 62(14): 3997 - 4006. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Harada, H. Miyoshi, N. Murai, H. Oshima, Y. Tamai, M. Oshima, and M. M. Taketo Lack of Tumorigenesis in the Mouse Liver after Adenovirus-mediated Expression of a Dominant Stable Mutant of {beta}-Catenin Cancer Res., April 1, 2002; 62(7): 1971 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Inagawa, M. Itabashi, S. Adachi, T. Kawamoto, M. Hori, J. Shimazaki, F. Yoshimi, and K. Fukao Expression and Prognostic Roles of {beta}-Catenin in Hepatocellular Carcinoma: Correlation with Tumor Progression and Postoperative Survival Clin. Cancer Res., February 1, 2002; 8(2): 450 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, M. Tondravi, J. Liu, E. Smith, C. C. Haudenschild, M. Kaczmarek, and X. Zhan Cortactin Potentiates Bone Metastasis of Breast Cancer Cells Cancer Res., September 1, 2001; 61(18): 6906 - 6911. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Deane, M. A. Parker, R. Aramandla, L. Diehl, W.-J. Lee, M. K. Washington, L. B. Nanney, Y. Shyr, and R. D. Beauchamp Hepatocellular Carcinoma Results from Chronic Cyclin D1 Overexpression in Transgenic Mice Cancer Res., July 1, 2001; 61(14): 5389 - 5395. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uto, A. Ido, A. Moriuchi, Y. Onaga, K. Nagata, M. Onaga, Y. Tahara, T. Hori, S. Hirono, K. Hayashi, et al. Transduction of Antisense Cyclin D1 Using Two-step Gene Transfer Inhibits the Growth of Rat Hepatoma Cells Cancer Res., June 1, 2001; 61(12): 4779 - 4783. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cadoret, C. Ovejero, S. Saadi-Kheddouci, E. Souil, M. Fabre, B. Romagnolo, A. Kahn, and C. Perret Hepatomegaly in Transgenic Mice Expressing an Oncogenic Form of {beta}-Catenin Cancer Res., April 1, 2001; 61(8): 3245 - 3249. [Abstract] [Full Text] |
||||
![]() |
H. Takayasu, H. Horie, E. Hiyama, T. Matsunaga, Y. Hayashi, Y. Watanabe, S. Suita, M. Kaneko, F. Sasaki, K. Hashizume, et al. Frequent Deletions and Mutations of the {beta}-Catenin Gene Are Associated with Overexpression of Cyclin D1 and Fibronectin and Poorly Differentiated Histology in Childhood Hepatoblastoma Clin. Cancer Res., April 1, 2001; 7(4): 901 - 908. [Abstract] [Full Text] |
||||
![]() |
L. C. Pulling, D. M. Klinge, and S. A. Belinsky p16INK4a and {beta}-catenin alterations in rat liver tumors induced by NNK Carcinogenesis, March 1, 2001; 22(3): 461 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Calvisi, V. M. Factor, R. Loi, and S. S. Thorgeirsson Activation of {beta}-Catenin during Hepatocarcinogenesis in Transgenic Mouse Models: Relationship to Phenotype and Tumor Grade Cancer Res., March 1, 2001; 61(5): 2085 - 2091. [Abstract] [Full Text] |
||||
![]() |
H. Dosaka-Akita, F. Hommura, T. Mishina, S. Ogura, M. Shimizu, H. Katoh, and Y. Kawakami A Risk-Stratification Model of Non-Small Cell Lung Cancers Using Cyclin E, Ki-67, and ras p21: Different Roles of G1 Cyclins in Cell Proliferation and Prognosis Cancer Res., March 1, 2001; 61(6): 2500 - 2504. [Abstract] [Full Text] |
||||
![]() |
A.-M. Hui, X. Li, Y.-Z. Shi, T. Takayama, G. Torzilli, and M. Makuuchi Cyclin D1 Overexpression Is a Critical Event in Gallbladder Carcinogenesis and Independently Predicts Decreased Survival for Patients with Gallbladder Carcinoma Clin. Cancer Res., November 1, 2000; 6(11): 4272 - 4277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Soria, S. J. Jang, F. R. Khuri, K. Hassan, D. Liu, W. K. Hong, and L. Mao Overexpression of Cyclin B1 in Early-Stage Non-Small Cell Lung Cancer and Its Clinical Implication Cancer Res., August 1, 2000; 60(15): 4000 - 4004. [Abstract] [Full Text] |
||||
![]() |
P. Polakis Wnt signaling and cancer Genes & Dev., August 1, 2000; 14(15): 1837 - 1851. [Full Text] |
||||
![]() |
K. Takaba, K. Saeki, K. Suzuki, H. Wanibuchi, and S. Fukushima Significant overexpression of metallothionein and cyclin D1 and apoptosis in the early process of rat urinary bladder carcinogenesis induced by treatment with N-butyl-N-(4-hydroxybutyl)nitrosamine or sodium L-ascorbate Carcinogenesis, April 1, 2000; 21(4): 691 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-L. Y. Feng, Y. Guo, V. M. Factor, S. S. Thorgeirsson, D. W. Bell, J. R. Testa, K. A. Peifley, and J. A. Winkles The Fn14 Immediate-Early Response Gene Is Induced During Liver Regeneration and Highly Expressed in Both Human and Murine Hepatocellular Carcinomas Am. J. Pathol., April 1, 2000; 156(4): 1253 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Huang, H. Fujii, A. Sankila, B. M. Mahler-Araujo, M. Matsuda, G. Cathomas, and H. Ohgaki {beta}-Catenin Mutations Are Frequent in Human Hepatocellular Carcinomas Associated with Hepatitis C Virus Infection Am. J. Pathol., December 1, 1999; 155(6): 1795 - 1801. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Carlson, T. Lahusen, S. Singh, A. Loaiza-Perez, P. J. Worland, R. Pestell, C. Albanese, E. A. Sausville, and A. M. Senderowicz Down-Regulation of Cyclin D1 by Transcriptional Repression in MCF-7 Human Breast Carcinoma Cells Induced by Flavopiridol Cancer Res., September 1, 1999; 59(18): 4634 - 4641. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. V. Nhieu, C. A. Renard, Y. Wei, D. Cherqui, E. S. Zafrani, and M. A. Buendia Nuclear Accumulation of Mutated {beta}-Catenin in Hepatocellular Carcinoma Is Associated with Increased Cell Proliferation Am. J. Pathol., September 1, 1999; 155(3): 703 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Q. Yang, H. Z. Lin, M. Yin, J. H. Albrecht, and A. M. Diehl Effects of chronic ethanol consumption on cytokine regulation of liver regeneration Am J Physiol Gastrointest Liver Physiol, October 1, 1998; 275(4): G696 - G704. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. A. M. Michalides, N. M. J. van Veelen, P. M. P. Kristel, A. A. M. Hart, B. M. Loftus, F. J. M. Hilgers, and A. J. M. Balm Overexpression of Cyclin D1 Indicates a Poor Prognosis in Squamous Cell Carcinoma of the Head and Neck Arch Otolaryngol Head Neck Surg, May 1, 1997; 123(5): 497 - 502. [Abstract] [PDF] |
||||
![]() |
H Wu, M Wade, L Krall, J Grisham, Y Xiong, and T Van Dyke Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration. Genes & Dev., February 1, 1996; 10(3): 245 - 260. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |